Partner and Collaborate Sample Clauses

Partner and Collaborate. Provide a clear and concise description of how the proposed project promotes collaborations with partners from multiple stakeholder groups, such as industry, business, academia, government, etc., to develop solutions that will address environmental and/or public health issues at the local level. We encourage applicants to seek diversity in partnerships in an effort to enhance the process of achieving the project’s goals. Applicants are strongly encouraged to have at least THREE signed letters of commitment from partners representing at least THREE different stakeholder groups submitted with their application. • Describe how the project will accomplish its goals through the use of appropriate and diverse partnerships from multiple stakeholder groups, such as industry, business, academia, government, etc. • Identify and describe all partners involved, including those partnerships that may be under development. Include the following details about each of your partners. If you are not planning on collaborating with other stakeholders or having partners for project performance, you must describe how you can effectively perform the project without such collaboration or partnerships: - Planned roles of each partner listed in your Project Summary. Include which stakeholder group the partner represents and the project activities each partner will be responsible for - how each partner will contribute to the project, - What resources each partner brings to the partnership - How the partner has a vested interest in working with this partnership [other than just getting income from a sub-award or contract] - How the applicant organization plans to maintain and sustain these relationships on into the future - If you intend to fund the partner’s participation in the project describe how the proposed financial transaction complies with applicable requirements in 2 CFR Part 200 or EPA Guidance on Participant Support Costs.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Partner and Collaborate. Provide a clear and concise description of how the proposed project promotes collaborations with partners from multiple stakeholder groups, such as industry, business, academia, government, etc., to develop and implement solutions that will address environmental and/or public health issues at the local level. We encourage applicants to seek diversity in partnerships in an effort to enhance the process of achieving the project’s goals. Applicants are strongly encouraged to have at least THREE signed letters of commitment from partners representing at least THREE different stakeholder groups. • Describe how the project will accomplish its goals through the use of appropriate and diverse partnerships from multiple stakeholder groups, such as industry, business, academia, government, etc. • Identify and describe all partners involved, including those partnerships that may be under development. Include the following details about each of your partners. If you are not planning on collaborating with other stakeholders or having partners for project performance, you must describe how you can effectively perform the project without such collaboration or partnerships: - Planned roles of each partner listed in your Project Summary. Include which stakeholder group the partner represents and the project activities each partner will be responsible for - What resources each partner brings to the partnership - How the partner has a vested interest in working with this partnership [other than just getting income from a sub-award or contract] - How the applicant organization plans to maintain and sustain these relationships on into the future Note About Commitment Letters: Applicants working with partners are strongly encouraged to submit at least THREE signed letters of commitment from partners. Letters should be from partners representing different stakeholder groups. All applicants should involve in their project at least THREE PARTNERS from THREE different stakeholder groups as documented by at least THREE signed letters of commitment. The letters must be submitted by the applicant with the other application documents by the submission deadline. The letters of commitment should include information about the role and activities each partner or stakeholder organization will perform as well as any resources the partner or stakeholder will provide. The letters of commitment must be signed by the partnering organizations. Do not include generic letters of support or recommen...
Sample 1Sample 2

Related to Partner and Collaborate

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • For clarity the time allowances provided in clause 2.10 shall operate to reduce the maximum timetabled classroom teaching time specified in clause 4.2 of this agreement.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

Time is Money Join Law Insider Premium to draft better contracts faster.